Not exact matches
In a novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long - term treatment using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative conditio
In a novel animal study design that mimicked human clinical trials, researchers at University
of California, San Diego School
of Medicine report that long - term treatment using a small molecule drug that reduces activity
of the brain's stress circuitry significantly reduces Alzheimer's
disease (
AD) neuropathology and prevents onset
of cognitive impairment
in a mouse model of the neurodegenerative conditio
in a
mouse model of the neurodegenerative condition.
First author Antonio Di Meco and colleagues used a triple transgenic (3xTg)
mouse model that displays an
AD - like phenotype, including cognitive decline, and Aβ and tau neuropathology characteristic
of the
disease in humans.
The phosphorylation
of eIF2alpha, which decreases protein synthesis, was previously found at elevated levels
in both humans diagnosed with Alzheimer's and
in Alzheimer's
Disease (
AD)
model mice.
In recent years, researchers have found that both humans with Alzheimer's
Disease and
AD model mice have relatively high levels
of eIF2alpha phosphorylation.
Engram cell
in AD mouse — This image depicts a single memory engram cell (green)
in the hippocampal dentate gyrus (DG) region
of a
mouse model of early Alzheimer's
disease.
The current project utilized an array
of immunochemical and molecular tools to perform a characterization
of retinal pathology
in the early stages
of disease progression using a well - validated
mouse model of AD (APPSWE / PS1ΔE 9).
Our recent study has demonstrated that peripheral amylin treatment reduces the amyloid pathology
in the brain
of Alzheimer's
disease (
AD)
mouse models, and improves their learning and memory.
Abstract: Our recent study has demonstrated that peripheral amylin treatment reduces the amyloid pathology
in the brain
of Alzheimer's
disease (
AD)
mouse models, and improves their learning and memory.